diazooxonorleucine has been researched along with Adenocarcinoma in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (71.43) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Dueñas-Gonzalez, A; Schcolnik-Cabrera, A | 1 |
| Anand, SK; Beer, DG; Carskadon, SL; Chakravarthi, BV; Chen, G; Chinnaiyan, AM; Giordano, TJ; Goswami, MT; Palanisamy, N; Pathi, SS; Thomas, DG; Varambally, S | 1 |
| Arakawa, M; Ardalan, B; Cooney, DA; Jayaram, H; Villacorte, D | 1 |
| Creagan, ET; Eagan, RT; Frytak, S; Ingle, JN; Nichols, WC | 1 |
| Moertel, CG; O'Connell, MJ; Rubin, J; Schutt, AJ; Sorensen, S; van Hazel, GA | 1 |
| Casper, ES; Magill, GB; Sklaroff, RB; Young, CW | 1 |
7 other study(ies) available for diazooxonorleucine and Adenocarcinoma
| Article | Year |
|---|---|
Mouse Model for Efficient Simultaneous Targeting of Glycolysis, Glutaminolysis, and De Novo Synthesis of Fatty Acids in Colon Cancer.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Colonic Neoplasms; Diazooxonorleucine; Drug Screening Assays, Antitumor; Fatty Acid Synthase, Type I; Fatty Acids; Female; Glutaminase; Glutamine; Glycolysis; Hexokinase; Indazoles; Mice; Mice, Inbred BALB C; Molecular Targeted Therapy; Orlistat; Smegmamorpha | 2021 |
Role and regulation of coordinately expressed de novo purine biosynthetic enzymes PPAT and PAICS in lung cancer.
Topics: Adenocarcinoma; Aged; Amidophosphoribosyltransferase; Aneuploidy; Animals; Biomarkers, Tumor; Carboxy-Lyases; Cell Line, Tumor; Cell Proliferation; Chickens; Diazooxonorleucine; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Glutamine; Humans; Lung Neoplasms; Male; Mice; Middle Aged; Neoplasm Invasiveness; Neoplasm Transplantation; Oligonucleotide Array Sequence Analysis; Peptide Synthases; Prognosis; Purines | 2015 |
Hypercalcemia of malignant disease.
Topics: Adenocarcinoma; Adrenal Gland Neoplasms; Animals; Breast Neoplasms; Diazooxonorleucine; Female; Humans; Hyperkalemia; Lung Neoplasms; Male; Rats | 1967 |
Effect of L-glutamine antagonists on 5-phosphoribosyl 1-pyrophosphate levels in P388 leukemia and in murine colon adenocarcinomas in vivo.
Topics: Adenocarcinoma; Animals; Azaserine; Colonic Neoplasms; Diazooxonorleucine; Glutamine; Intestine, Small; Isoxazoles; Leukemia P388; Leukemia, Experimental; Mice; Neoplasms, Experimental; Pentosephosphates; Phosphoribosyl Pyrophosphate | 1982 |
Phase II study on DON in patients with previously treated advanced lung cancer.
Topics: Adenocarcinoma; Aged; Antibiotics, Antineoplastic; Azo Compounds; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Diazooxonorleucine; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Middle Aged; Prognosis | 1982 |
A phase II study of 6-diazo-5-oxo-L-norleucine (DON, NSC-7365) in advanced large bowel carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Azo Compounds; Colonic Neoplasms; Diazooxonorleucine; Drug Evaluation; Female; Humans; Male; Middle Aged; Nausea; Rectal Neoplasms; Vomiting | 1983 |
Phase I study of 6-diazo-5-oxo-L-norleucine (DON).
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Azo Compounds; Bone Marrow; Carcinoma, Squamous Cell; Diazooxonorleucine; Drug Administration Schedule; Drug Evaluation; Female; Humans; Male; Middle Aged; Nausea; Neoplasms; Vomiting | 1980 |